Multiple neuroimaging studies using positron emission tomography (PET) to track in vivo pathological processes in AD showed that cortical Aβ deposition precedes neocortical tau aggregation by several years1,3, and Aβ has been shown to amplify tau spreading in preclinical studies4,5. The gene discussed is MAPT; the disease is Alzheimer disease.